Sentinel Node Biopsy Market growth top key players size and recent trends by forecast to 2022
Sentinel node biopsy is a medical procedure sued for the diagnosis of various types of cancer such as breast cancer, colon cancer, and others.
There are various factors affecting the growth of the market such as increasing prevalence of cancer, technological advancement, and others. Additionally, extensive R&D activities in the diagnosis and treatment of cancer further fuel the market growth. Rising healthcare funding by the government organizations also accelerates the market growth. However, the high cost of the diagnostic procedure may affect the market growth.
The global sentinel node biopsy market is expected to grow at a CAGR of 5.1% during the forecast period 2017-2023.
Industry Segmentation
Sentinel Node Biopsy Market Research Report– Information: By-Product (Breast Localization Wire, Tissue Marker, Gamma Probe, Drainage Catheters), Indication (Breast Cancer, Melanoma, Colon Cancer, Esophageal Cancer), End User (Hospitals & Clinics, Diagnostic Centers) – Global Forecast Till 2023.
global sentinel node biopsy market is segmented on the basis of product, indication, and end user.
On the basis of the product, the market is segmented into
- breast localization wire,
- tissue marker,
- gamma probe,
- drainage catheter,
- and others.
On the basis of the indication, the market is segmented into
- breast cancer,
- melanoma,
- colon cancer,
- esophageal cancer,
- and others.
On the basis of the end user, the market is segmented into
- hospitals & clinics,
- diagnostic centers,
- and others.
Competitive Analysis by Major Key Players
Some of key the players in the market are Devicor Medical Products, Inc., part of Leica Biosystems. (Germany), C. R. Bard, Inc. (U.S.), INTRAMEDICAL IMAGING LLC (U.S.), Hilfe Engineering Corporation (India), Surgic Eye (Germany), KUB Technologies, Inc. (U.S.), Navidea Biopharmaceuticals, Inc.(U.S.) and others.
Browse Complete Premium Research Report https://www.marketresearchfuture.com/reports/sentinel-node-biopsy-market-5582
Comprehensive Regional Analysis
The Americas dominate the global sentinel node biopsy market owing to the rising number of patients with cancer, raising awareness about biopsy as a cancer diagnostic tool, and increasing government support for research & development.
Europe acquires the second largest share of the global sentinel node biopsy market as result of increasing focus of various government agencies on the treatment of various chronic and fatal diseases.
In the Asia Pacific, the market growth is driven by rising healthcare expenditure in major economies, growing the government initiatives for research & development are projected to drive the market in China and India and high prevalence of chronic diseases.
The United Arab Emirates (UAE), Saudi Arabia, and Kuwait are a major market in the Middle East due to the exponential growth of healthcare diagnostic industry and the demand for specialty care services.
About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar, Pune
+1 646 845 9312
Email: sales@marketresearchfuture.com
